Bedell Frazier Investment Counselling’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Bedell Frazier Investment Counselling's PFE Position: Q1 2026 in Review
Bedell Frazier Investment Counselling increased its Pfizer (PFE) stake by 2.9% in Q1 2026, buying an estimated $20.2K and bringing the position to 27,153 shares worth $762K. The position accounts for 0.15% of the portfolio, ranked #79.
Bedell Frazier Investment Counselling first reported a position in PFE in Q1 2017 and has held it in 18 quarters since. The position peaked at $6.71M in Q4 2017. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bedell Frazier Investment Counselling held 27,153 shares of Pfizer worth $762K as of Q1 2026.
- Bedell Frazier Investment Counselling bought 758 Pfizer shares in Q1 2026, an estimated $20.2K.
- Pfizer made up 0.15% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #79 holding.
- Bedell Frazier Investment Counselling first reported a position in Pfizer in Q1 2017 and has held it in 18 quarters since.
- Bedell Frazier Investment Counselling's Pfizer position peaked at $6.71M in Q4 2017.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.